Company Filing History:
Years Active: 2012
Title: The Innovations of Pascal H Toma: A Pioneer in Crystalline Compounds
Introduction: Pascal H Toma is an accomplished inventor hailing from Cary, North Carolina, known for his innovative contributions to the field of pharmaceutical compounds. With a keen focus on developing compounds with beneficial medical uses, Toma has made significant strides in his career, holding one notable patent that marks his influence in the industry.
Latest Patents: Toma's sole patent, titled "Crystalline Form of the Compound A-348441," is a groundbreaking achievement in the realm of medicinal chemistry. This particular patent describes a hemihydrate version of a complex compound, characterized by its specific X-ray diffraction pattern showcasing major peaks at 2θ=6.58±0.2, 8.54±0.2, 12.28±0.2, and 19.68±0.2. The crystalline material has promising applications in treating conditions linked to an excess of hepatic glucocorticoid response, showcasing Toma's commitment to addressing significant health issues through innovation.
Career Highlights: Toma has built his career at Karo Bio AB, a company recognized for its cutting-edge research and development in pharmaceuticals. His work involves leveraging his expertise to push the boundaries of current scientific understanding and to contribute to the development of effective therapeutic solutions that can improve patient outcomes.
Collaborations: Throughout his career, Pascal H Toma has collaborated with esteemed colleagues, including Russell Drew Cink and Daozhong Zou. These partnerships reflect Toma's belief in the power of collaboration to foster innovation and drive advancements in the pharmaceutical sector, leading to more effective treatments and solutions.
Conclusion: Pascal H Toma stands out as a prominent figure in the field of pharmaceutical innovation. With his patented work and collaborations, he contributes to the ongoing development of substances designed to combat significant health challenges. As he continues to work at Karo Bio AB, Toma remains dedicated to the advancement of science and the creation of new therapeutic options for patients in need.